Scottish Government funding for neurodegenerative drug discovery research

Our group has been awarded proof-of-concept funding from the Scottish Government to develop a groundbreaking drug screening platform for Parkinson's disease.

The technology enables high-throughput screening of compounds that target the small, soluble forms of misfolded proteins believed to drive neurodegeneration. Until now, these species have been impossible to measure at the scale required for drug discovery. The platform will also be adaptable to Alzheimer's disease, Motor Neuron Disease, and other protein-aggregation conditions.


This funding allows us to take a technology that works in a specialised optics lab and prove it can operate at industrial scale. This will enable us to screen thousands of compounds per day, seeing if any of them can remove the species that cause damage in Parkinson’s disease



Comments

Post a Comment

Popular posts from this blog

Synuclein meeting 2025 in Cambridge

Image
  Last week, some members of the ESMB group attended the Synuclein meeting 2025 to hear about current and future approaches to target synulceinopathies. This event offered a very varied programme, with talks ranging from clinical and pre-clinical studies in the field of Parkinson’s disease and Multiple System Atrophy all the way to super-resolution imaging of aSynuclein aggregates. It was an amazing experience to get to hear from groups that have changed this field over the years and also to see all the new projects being set up to study these diseases onset and progression, therapies and diagnosis. It felt like going back to the origins of the group, where it all started! Finally, Gala dinner/party at King’s College Hall was definitely a highlight of the programme.
Read more

Congratulations to Dan on getting a prestigious post-doctoral fellowship

Image
Dan Edwards, a postdoctoral research associate in the group, has been awarded a prestigious early postdoctoral fellowship from the Chief Scientist Office (CSO), part of the Scottish Government Health Directorate. Dan did his PhD with Prof. Scott Cockroft and Dr Amanda Jarvis, and joined the ESMB group as part of a Leverhulme-funded project between Prof. Scott Cockroft and Prof. Mathew Horrocks. Dan has previously won the Institute for Regeneration and Repair's Innovator 2026 competition, and runs an outreach science activity funded by AIBIO-UK. He's also on the School's Post-Doc Committee.   Dan will begin the three-year fellowship this year with a project focused on advancing Parkinson's disease diagnosis through biomarkers that enable early detection from accessible biofluids.  On the award, Dan said: "It is an honour to be awarded the CSO early postdoctoral fellowship. This award will give me the time and resources to develop assays to improve our approaches to ...
Read more

Zoe wins a Sir William Darling Memorial Prize for enhancing the reputation of the University of Edinburgh

Image
Huge congratulations to Zoe Gidden, who has been awarded a Sir William Darling Memorial Prize of £1000. Traditionally, this Prize is awarded to an individual or group of students who have done most to enhance the reputation of the University. Zoe has done this firstly through her role on the University swim team, which has resulted in her winning multiple events: Scottish National Masters Champion 2021 25-29 yrs in 50m butterfly, 50m freestyle, 100m freestyle, 200m freestyle and 100m individual medley. Achieving times that were faster than the Scottish age group record in the 50m and 100m freestyle. Scottish National Masters Champion 2022 25-29 yrs in 50m butterfly, 50m freestyle, 100m freestyle and 100m individual medley. Again, achieving times faster than the Scottish age group record in the 50m and 100m freestyle. Represented the University of Edinburgh in Scottish Student Sport League Division 1 matches. In addition to her sporting achievements, Zoe has also enhanced the reputation...
Read more